Al-Razi Medical Past Earnings Performance
Past criteria checks 1/6
Al-Razi Medical's earnings have been declining at an average annual rate of -2.3%, while the Healthcare industry saw earnings growing at 15.4% annually. Revenues have been growing at an average rate of 20.7% per year. Al-Razi Medical's return on equity is 8.9%, and it has net margins of 3.5%.
Key information
-2.3%
Earnings growth rate
-2.3%
EPS growth rate
| Healthcare Industry Growth | 12.3% |
| Revenue growth rate | 20.7% |
| Return on equity | 8.9% |
| Net Margin | 3.5% |
| Last Earnings Update | 30 Jun 2023 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses Breakdown
How Al-Razi Medical makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 23 | 59 | 2 | 15 | 0 |
| 31 Mar 23 | 56 | 2 | 14 | 0 |
| 31 Dec 22 | 52 | 2 | 13 | 0 |
| 31 Dec 21 | 45 | 2 | 11 | 0 |
Quality Earnings: 9572 has high quality earnings.
Growing Profit Margin: 9572's current net profit margins (3.5%) are lower than last year (4.3%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if 9572's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: 9572's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 9572 had negative earnings growth (-2.3%) over the past year, making it difficult to compare to the Healthcare industry average (34.9%).
Return on Equity
High ROE: 9572's Return on Equity (8.9%) is considered low.